Takeaway
Combining magnetic resonance imaging (MRI) and electroencephalography (EEG) markers provide an accurate assessment of cognitive impairment in early Alzheimer's disease (AD).
Why this matters
This combined MRI–EEG approach could be a non-invasive and cost-effective way to assist diagnosis of early AD; resulting in timely treatment and aiding clinical AD research.